Citadel Advisors’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.3K | Sell |
12,831
-151,210
| -92% | -$947K | ﹤0.01% | 5337 |
|
|
2025
Q1 | $961K | Buy |
164,041
+156,263
| +2,009% | +$916K | ﹤0.01% | 3328 |
|
|
2024
Q4 | $63.9K | Buy |
7,778
+6,767
| +669% | +$55.6K | ﹤0.01% | 5385 |
|
|
2024
Q3 | $9.01K | Sell |
1,011
-2,337,654
| -100% | -$20.8M | ﹤0.01% | 5460 |
|
|
2024
Q2 | $17.7M | Sell |
2,338,665
-1,337,607
| -36% | -$10.1M | ﹤0.01% | 928 |
|
|
2024
Q1 | $28.9M | Buy |
3,676,272
+44,978
| +1% | +$353K | 0.01% | 719 |
|
|
2023
Q4 | $32.2M | Buy |
3,631,294
+1,147,227
| +46% | +$10.2M | 0.01% | 646 |
|
|
2023
Q3 | $22.3M | Buy |
2,484,067
+23,486
| +1% | +$211K | ﹤0.01% | 748 |
|
|
2023
Q2 | $30.4M | Sell |
2,460,581
-41,640
| -2% | -$514K | 0.01% | 618 |
|
|
2023
Q1 | $23.2M | Sell |
2,502,221
-234,832
| -9% | -$2.18M | 0.01% | 781 |
|
|
2022
Q4 | $28.7M | Buy |
2,737,053
+424,735
| +18% | +$4.46M | 0.01% | 692 |
|
|
2022
Q3 | $41.9M | Buy |
2,312,318
+159
| +0% | +$2.88K | 0.01% | 470 |
|
|
2022
Q2 | $32.8M | Sell |
2,312,159
-4,494
| -0.2% | -$63.7K | 0.01% | 580 |
|
|
2022
Q1 | $48.3M | Buy |
2,316,653
+1,551
| +0.1% | +$32.3K | 0.01% | 457 |
|
|
2021
Q4 | $37.3M | Buy |
+2,315,102
| New | +$37.3M | 0.01% | 617 |
|